REFERENCES
Sutton, S. C., Evans, L. A., Rinaldi, M. T. S., Norton, K. A., Pharm. Res. (in print).
G. A. Brazeau, and H. L. Fung, J. Pharm. Res., 6, 167 (1989).
O. Svendsen, F. Hojelse, and R. E. Bagdon, Acta Pharmacol. Toxicol., 56, 183 (1985).
P. D. Williams, B. G. Masters, L. D. Evans, D. A. Laska, and G. H. Hottendorf, Fundam. Appl. Toxic., 9, 10 (1987).
D. M. Hoover, J. B. Gardner, T. L. Timmerman, J. A. Klepfer, D. A. Laska, S. A. White, J. P. McGrath, M. K. Beuning, P. D. Williams, Fundam. Appl. Toxic., 14, 589 (1990).
PMA/Drug Safety Subsection (Drusafe) In Vitro Toxicology Task Force: A Collaborative Evaluation of an In Vitro Muscle Irritation Assay. Toxicology Methods, 4, 215–223, 1994.
Sutton, S. C., Evans, L. A., Rinaldi, M. T. S., Norton, K. A.: Pharm Res. (in print).
D. A. Laska, P. D. Williams, S. L. White, C. A. Thompson, and D. M. Hoover, In Vitro Cell. Dev. Biol. 16, 393 (1990).
E. Steiness, O. Svendsen, F. Rasmussen: Clin. Pharmacol. Ther. 16, 430–434, 1974.
Brazeau G. A., S. S. Watts, and L. S. Mathews, J Parent Sci Tech, 46, 25–30, 1992.
G. A. Brazeau and H.-L. Fung, Biochem J 257, 619–621, (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Evans, L.A.F., Genereux, P.E., Gibbs, E.M. et al. Predicting Injection Site Muscle Damage III: Evaluation of Intramuscular Formulations in the L6 Cell Model. Pharm Res 13, 1585–1587 (1996). https://doi.org/10.1023/A:1016004318459
Issue Date:
DOI: https://doi.org/10.1023/A:1016004318459